Business Daily.
.
A+ R A-

Baxalta Launches as a Global Biopharmaceutical Leader Dedicated to Patients with Orphan Diseases and Underserved Conditions

E-mail Print PDF
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxalta Incorporated (NYSE: BXLT) launches today as a global biopharmaceutical company dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions.

imageimage
Grow Your Business with Times Media
Business Daily Media